Intrinsic Value
Xeris Biopharma Holdings, Inc. (XERS)
$1.75
+0.05 (+2.94%)
| Enterprise Value | -91,382.26 |
|---|---|
| Net Debt | 161.74 |
| Equity Value | -91,544 |
| Shares Outstanding | 137.67 |
| Equity Value Per Share | -664.93 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt